RxDoctor Payments Data

Shahed Badiyan, MD

Radiation Oncology · Saint Louis, MONPI 1285967141

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,800 of the $5,968 with a category attached, or 80.4%. Reflexion Medical, Inc. accounts for 61.8% of it on its own, with 9 other manufacturers making up the rest. 2024 is the largest year on record at $4,000, more than ten times the $137 reported in 2019.

$5,968in general payments, 2019–2025

Across 18 payments — averaging $331.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Reflexion Medical, Inc.$4K
  • Mevion_medical_systems_inc$2K
  • Elekta, Inc.$239
  • Abbott$129
  • Telix Pharmaceuticals$128
  • Biosense Webster, Inc.$117
  • plus $167 from 4 others
$472,772in research payments, 2019–2025

Across 11 payments — averaging $42,979 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$473K

What the payments were for

  • Speaking & faculty fees$4,80080%
  • Travel & lodging$3376%
  • Food & beverage$83114%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,968 in reported general payments places this provider in the 80th percentile of 123 radiation oncology providers in Missouri.

See all radiation oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$222,070
Medicare patients
128
Services billed
2,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →